BioInsights - BioInsights

VACCINE INSIGHTS

April 2023 Issue

Vol 2 Issue 4

Advances in vaccine manufacturing Part 1: Upstream advances and intensifying production

Featuring this month's spotlight content:

Advances in vaccine manufacturing Part 1: Upstream advances and intensifying production
View
Vaccine Insights Vol 2 Issue 4
View

Upcoming webinars

Early-stage considerations for cell and gene therapy commercialization

Early-stage considerations for cell and gene therapy commercialization

Sabrina Carmichael
11 October
in 17
Days
Register
Scalable, high titer production of AAV in the Gibco CTS AAV_Max production system

Scalable, high titer production of AAV in the Gibco CTS AAV_Max production system

Jonathan Zmuda PhD
22 December
in 89
Days
Register
View all webinars

Latest Articles

Resolving facility design conflicts between biocontainment & good manufacturing practices for vaccines manufacture

Resolving facility design conflicts between biocontainment & good manufacturing practices for vaccines manufacture

Faye Litherland, Ranna Eardley-Patel
2 May
Expert Insight
Understanding and improving immune responses to RNA vaccines

Understanding and improving immune responses to RNA vaccines

Justin Richner
2 May
Interview
Validating a rapid analytical method for plasmid purity determination & platform harmonization

Validating a rapid analytical method for plasmid purity determination & platform harmonization

Joe Ferraiolo
2 May
Innovator Insight
Optimizing adenovirus vector-based vaccine production

Optimizing adenovirus vector-based vaccine production

Carina Joe
27 April
Interview
Pushing the frontiers of mRNA formulation & delivery

Pushing the frontiers of mRNA formulation & delivery

Mohamed EH ElSayed
23 April
Interview
Expanding horizons with mRNA vaccines against bacteria

Expanding horizons with mRNA vaccines against bacteria

Nicholas K Clark, Leah Cole
23 April
Viewpoint
Opportunities and challenges in mRNA-LNP vaccine design

Opportunities and challenges in mRNA-LNP vaccine design

Rein Verbeke, Pieter R Cullis
17 April
Viewpoint
Rapid manufacturing of vaccines for pandemic response & personalized cancer: parallels to leverage for common pathways to expedite clinical development?

Rapid manufacturing of vaccines for pandemic response & personalized cancer: parallels to leverage for common pathways to expedite clinical development?

Antu K. Dey
15 April
Viewpoint
Leveraging modernization of the US influenza vaccine manufacturing base to make better vaccines: a work in progress

Leveraging modernization of the US influenza vaccine manufacturing base to make better vaccines: a work in progress

Robert C Huebner
14 April
Viewpoint